PCRX - Pacira Biosciences announces proposed offering of $250M aggregate principal amount of convertible senior notes May, 08 2024 04:36 PM Pacira BioSciences Inc. 2024-05-08 16:36:45 ET More on Pacira BioSciences Pacira BioSciences up 12% on stock buyback, Q1 top-line beat Pacira BioSciences GAAP EPS of $0.54 beats by $0.15, revenue of $181.2M beats by $0.34M For further details see: Pacira Biosciences announces proposed offering of $250M aggregate principal amount of convertible senior notes